Li et al., 2021 - Google Patents
Interferon-α-producing plasmacytoid dendritic cells drive the loss of adipose tissue regulatory T cells during obesityLi et al., 2021
View HTML- Document ID
- 3905515476174119044
- Author
- Li C
- Wang G
- Sivasami P
- Ramirez R
- Zhang Y
- Benoist C
- Mathis D
- Publication year
- Publication venue
- Cell metabolism
External Links
Snippet
The visceral adipose tissue (VAT) of lean mice hosts a unique population of regulatory T cells (Tregs) that have a distinct transcriptome and T cell receptor (TCR) repertoire and regulate local and systemic inflammation and metabolism. Perplexingly, this population …
- 210000004443 Dendritic Cells 0 title abstract description 45
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues ; Not used, see subgroups
- C12N5/0602—Vertebrate cells
- C12N5/0634—Cells from the blood or the immune system
- C12N5/0636—T lymphocytes
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/5044—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
- G01N33/5047—Cells of the immune system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/21—Interferons [IFN]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/20—Interleukins [IL]
- A61K38/2026—IL-4
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Li et al. | Interferon-α-producing plasmacytoid dendritic cells drive the loss of adipose tissue regulatory T cells during obesity | |
Si et al. | Hematopoietic progenitor kinase1 (HPK1) mediates T cell dysfunction and is a druggable target for T cell-based immunotherapies | |
Turnis et al. | Interleukin-35 limits anti-tumor immunity | |
Tu et al. | T cell receptor-regulated TGF-β type I receptor expression determines T cell quiescence and activation | |
Engblom et al. | Osteoblasts remotely supply lung tumors with cancer-promoting SiglecFhigh neutrophils | |
Grinberg-Bleyer et al. | NF-κB c-Rel is crucial for the regulatory T cell immune checkpoint in cancer | |
Barsheshet et al. | CCR8+ FOXp3+ Treg cells as master drivers of immune regulation | |
Qin et al. | Insights into the molecular mechanisms of T follicular helper-mediated immunity and pathology | |
Polycarpou et al. | A systematic review of immunological studies of erythema nodosum leprosum | |
Kratochvill et al. | TNF counterbalances the emergence of M2 tumor macrophages | |
Kunz et al. | Interleukin (IL)‐19, IL‐20 and IL‐24 are produced by and act on keratinocytes and are distinct from classical ILs | |
Hasegawa et al. | Therapeutic effect of CXCR3-expressing regulatory T cells on liver, lung and intestinal damages in a murine acute GVHD model | |
Staudt et al. | Interferon-regulatory factor 4 is essential for the developmental program of T helper 9 cells | |
Pöllinger et al. | Th17 cells, not IL-17+ γδ T cells, drive arthritic bone destruction in mice and humans | |
Shevach | Mechanisms of foxp3+ T regulatory cell-mediated suppression | |
Narni-Mancinelli et al. | Tuning of natural killer cell reactivity by NKp46 and Helios calibrates T cell responses | |
Martin-Orozco et al. | T helper 17 cells promote cytotoxic T cell activation in tumor immunity | |
Whitley et al. | Local IL-23 is required for proliferation and retention of skin-resident memory TH17 cells | |
Cai et al. | Tim-3 expression represents dysfunctional tumor infiltrating T cells in renal cell carcinoma | |
Morita et al. | Egr2 and Egr3 in regulatory T cells cooperatively control systemic autoimmunity through Ltbp3-mediated TGF-β3 production | |
Yokoyama et al. | IL-2–anti–IL-2 monoclonal antibody immune complexes inhibit collagen-induced arthritis by augmenting regulatory T cell functions | |
Kroemer et al. | OX40 controls functionally different T cell subsets and their resistance to depletion therapy | |
Wang et al. | Circadian tumor infiltration and function of CD8+ T cells dictate immunotherapy efficacy | |
Zhang et al. | mTOR limits the recruitment of CD11b+ Gr1+ Ly6Chigh myeloid-derived suppressor cells in protecting against murine immunological hepatic injury | |
Zhang et al. | The critical role of myeloid-derived suppressor cells and FXR activation in immune-mediated liver injury |